Angiotensin-(1-7) in hypertension

Citation
Mc. Chappell et Cm. Ferrario, Angiotensin-(1-7) in hypertension, CURR OP NEP, 8(2), 1999, pp. 231-235
Citations number
38
Categorie Soggetti
Urology & Nephrology
Journal title
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
ISSN journal
10624821 → ACNP
Volume
8
Issue
2
Year of publication
1999
Pages
231 - 235
Database
ISI
SICI code
1062-4821(199903)8:2<231:AIH>2.0.ZU;2-R
Abstract
Recent evidence suggests that angiotensin-(1-7) is a bioactive component of the renin-angiotensin system that may oppose or, in certain situations con tribute to the actions of Ang II. Ang-(1-7) can be directly formed from Ang I bypassing the requisite production of Ang II. In contrast to forming Ang II, angiotensin-converting enzyme hydrolyses Ang-(1-7) to inactive fragmen ts. Angiotensin-converting enzyme inhibitors substantially augment circulat ing levels of Ang-(1-7) and increase the peptide's half-life six-fold. Thus , angiotensin-converting enzyme may constitute an important regulatory poin t to balance the actions of Ang II, Ang-(1-7) and bradykinin. Indeed, Ang-( 1-7) can potentiate the actions of bradykinin through a receptor-mediated s ite and a direct interaction with angiotensin-converting enzyme. We summari ze recent studies that reveal depressor, vasodilator, and antihypertensive actions of Ang-(1-7) thus providing evidence that Ang-(1-7) is the antihype rtensive peptide of the renin-angiotensin system. Curr Opin Nephrol Hyperte ns 8:231-235. (C) 1999 Lippincott Williams & Wilkins.